
Madhav Seshadri
Asst Clinical Professor · University of California (San Francisco) School of Medicine
Credentials: · · · · ·
History


- 2012–2016
2005–2009
Research
Snapin mediates incretin action and augments glucose-dependent insulin secretion
Cell Metabolism · 2011 · 97 citations
Anti-complement C5 therapy with eculizumab in three cases of critical COVID-19
Case report · Clinical Immunology · 2020 · 94 citations
Journal of the National Comprehensive Cancer Network · 2024 · 63 citations

3 papers

2 papers
- BK
2 papers

2 papers

2 papers

2 papers

2 papers

2 papers
Clinical trials
- 2024–2028
Glofitamab With Pirtobrutinib for Relapsed or Refractory Mantle Cell Lymphoma
Principal investigator · Recruiting · Phase 2
University of California, San Francisco
- 2023–2030
Site PI · Recruiting · Phase 2
SWOG Cancer Research Network


